French Stock News

In the past week, Groupe SEB revised its full-year 2025 guidance, expecting stable to slightly positive organic sales growth and lowering its operating result forecast to €550 million–€600 million due to increased competition and softer demand in Europe and the US. This guidance update represents a meaningful shift as it reflects heightened pressures in key geographic markets, prompting a more cautious stance for year-end performance. We'll examine how SEB's reduced outlook, especially the...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

To the annoyance of some shareholders, Solutions 30 SE ( EPA:S30 ) shares are down a considerable 29% in the last...

While Ipsos SA ( EPA:IPS ) might not have the largest market cap around , it saw significant share price movement...

Thinking about what to do with Valneva stock right now? You're not alone. After an eye-catching 111.0% gain so far this year and a robust 31.8% jump over the past month, anyone curious about biotech movers is watching Valneva a bit closer. Seven-day returns are strong too, up 6.5%. However, if you zoom out to three or five years, you’ll see the stock is still deep in the red, trailing by over 20%. That’s quite a ride, which makes any decision more interesting for investors navigating both...

If you are watching Edenred right now and wondering whether this is the moment to buy, hold, or walk away, you are in good company. The recent ups and downs in Edenred's stock have left plenty of investors scratching their heads. On the one hand, the past year has been tough, with the stock dropping by 34.6% and lagging even further behind over the last three years. On the other hand, just this past week, Edenred delivered a bounce of 5.5%, which suggests renewed interest and possibly even an...

If you're considering adding Forvia to your portfolio, you're not alone. Investors are buzzing about what’s next for the stock. After a challenging stretch in recent years, Forvia has shown clear signs of regaining its footing. Year to date, shares are up a strong 31.1%, and the one-year return stands at 34.3%. Even in the past month alone, the stock has delivered an 8.0% gain, signaling renewed interest and shifting market sentiment around the company’s prospects. Of course, the story isn’t...

If you have been watching Valeo, you are probably wondering whether its current stock price of €10.66 represents a smart opportunity or just another stop in a long road of volatility. The stock’s journey has been far from dull. Just look at the numbers: while Valeo gained 3.3% over the past month and is up a solid 13.2% year-to-date, its three- and five-year returns tell a different story, with declines of -25.7% and -56.3% respectively. Over the last week, Valeo slipped by -0.7%, hinting at...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Bonduelle SCA's ( EPA:BON ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...

If you have been watching Legrand lately and wondering whether now is the right time to jump in or take your profits, you are definitely not alone. The stock has been a standout performer, and just glancing at its numbers, it is hard not to be impressed. With a return of 52.5% since the start of the year and a one-year climb of 43.8%, Legrand has not only defied cautious sentiment but managed to outpace the broader market. Even over the last three years, the stock has soared an impressive...

Thinking about what to do with Eutelsat Communications stock? You are not alone. All eyes are on the company after a dramatic resurgence in its share price, and with some big valuation questions still on the table, it is the kind of moment that makes both new investors and seasoned holders pause for a closer look. Over the last week, Eutelsat saw its share price climb 10.7%. Stretch that view out to one month, and the return balloons to 31.1%, fuelled by renewed optimism about satellite...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 16x, you may consider...

Those holding Voltalia SA ( EPA:VLTSA ) shares would be relieved that the share price has rebounded 28% in the last...

Soft earnings didn't appear to concern Alten S.A.'s ( EPA:ATE ) shareholders over the last week. We think that the...

Eurofins-Cerep (ENXTPA:ALECR) reported net profit margins of 17.7%, a slight uptick from last year’s 17.3%. The company has delivered average annual earnings growth of 3.2% over the past five years, but recent results show negative earnings growth year over year, making short-term comparisons less meaningful for now. Investors are likely to focus on the attractive valuation, as the stock trades at a Price-To-Earnings Ratio of 12.8x, which is well below both the peer group (60.7x) and the...

If you’re one of the many investors eyeing 74Software right now, you’re not alone. Deciding what to do with this stock isn’t just about gut feel or recent headlines, either. The company’s share price has definitely kept things interesting, with a 1.6% climb over the past week after a modest dip of 3.9% in the last month. Looking beyond the short term, 74Software’s story is quite compelling, with a 41.1% increase year-to-date, a 54.5% rise over the past twelve months, and a remarkable 147.1%...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

WALLIX GROUP SA ( EPA:ALLIX ) shareholders would be excited to see that the share price has had a great month, posting...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...

If you have been watching Exosens lately, you might be wondering whether now is the right time to jump in or take some profits. With the stock recently closing at $43.65 and putting up a jaw-dropping 126.9% gain since the start of the year, Exosens has gone from a quiet name to a real market mover overnight. The last 30 days alone have been impressive, up 16.2%, and that momentum is not going unnoticed. So, what is driving all this action? Beyond general bullish sentiment, investors seem to...

Valneva (ENXTPA:VLA) shares have experienced sharp changes over the past month, capturing investor attention as the biotech firm navigates broader sector moves and fresh financial results. The company’s stock saw an impressive upswing during this period. See our latest analysis for Valneva. Valneva’s share price has shown some renewed energy lately, posting a modest gain over the past month as the company’s story continues to evolve alongside recent sector news. While short-term price...

Thinking about what to do with your shares of Métropole Télévision or considering jumping in? You are definitely not alone. This stock has quietly delivered a total return of 17.6% over the past year, and a striking 75.5% if you broaden out to five years. Such consistent gains suggest more than just a lucky streak. Even in the past seven days, the price inched up by 0.3%, showing some underlying stability despite the usual market buzz. Look even closer and you will see that the company is up...